Acquisitions and Divestitures - Estimated Useful Life and Fair Value (Detail) - 908 Devices Inc. Bioprocessing Analytics Portfolio $ in Thousands |
9 Months Ended |
|---|---|
|
Sep. 30, 2026
USD ($)
| |
| Business Combination [Line Items] | |
| Fair Value | $ 13,610 |
| Customer relationships | |
| Business Combination [Line Items] | |
| Fair Value | $ 5,040 |
| Customer relationships | Maximum | |
| Business Combination [Line Items] | |
| Useful life | 9 years |
| Customer relationships | Minimum | |
| Business Combination [Line Items] | |
| Useful life | 8 years |
| Developed technology | |
| Business Combination [Line Items] | |
| Fair Value | $ 6,910 |
| Developed technology | Maximum | |
| Business Combination [Line Items] | |
| Useful life | 12 years |
| Developed technology | Minimum | |
| Business Combination [Line Items] | |
| Useful life | 10 years |
| Trademark and tradename | |
| Business Combination [Line Items] | |
| Fair Value | $ 1,660 |
| Trademark and tradename | Maximum | |
| Business Combination [Line Items] | |
| Useful life | 14 years |
| Trademark and tradename | Minimum | |
| Business Combination [Line Items] | |
| Useful life | 13 years |
| X | ||||||||||
- Definition Weighted-average period of amortization for finite-lived intangible asset acquired in business combination, asset acquisition, and from joint venture formation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of identifiable finite-lived intangible asset acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|